Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.59
-0.14 (-1.44%)
Dec 20, 2024, 4:00 PM EST - Market closed
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $471.58 million as of December 20, 2024. Its market cap has decreased by -10.67% in one year.
Market Cap
471.58M
Enterprise Value
425.20M
1-Year Change
-10.67%
Ranking
Category
Stock Price
$9.59
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $471.58M, a decrease of -36.33%. That is a compound annual growth rate of -4.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 471.60M | -15.74% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Third Harmonic Bio | 488.43M |
| Verve Therapeutics | 485.97M |
| MeiraGTx Holdings | 480.64M |
| PureTech Health | 480.54M |
| Alumis | 479.87M |
| Celcuity | 462.63M |
| DocGo | 460.25M |
| Kodiak Sciences | 454.14M |